All In MedTech

Device Trial Radar · NCT00922649

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Sep 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

58

Actual

Start

Feb 1, 2008

Primary completion

Dec 1, 2008

Study completion Jan 1, 2009

Sponsor

Lead sponsor
Animas CorporationNot on our public-company list
Sponsor type
Industry
First posted
Jun 17, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Device feasibility
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

16-week, open-label, multi-center pilot study. Insulin pump naïve subjects with type 2 diabetes who are not achieving glycemic targets (screening A1C ≥ 7.0%) on an established regimen of either: 1) ≥ 2 OAs (Cohort A), 2) basal insulin ± OAs (Cohort B), or 3) basal-bolus insulin ± OAs (Cohort C) will initiate basal-bolus therapy with an insulin pump using a rapid-acting insulin analog.

Conditions

  • Type 2 Diabetes

Interventions

  • Insulin Pump therapyDevice

    Initiation of Insulin pump therapy in patients on \>2 OAs (Cohort A), basal insulin ± OAs (Cohort B), or basal-bolus insulin ± OAs (Cohort C.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Insulin doses at Week 16Time frame: Week 16
  2. Ratio of Basal-to-Bolus Insulin Dose at Week 16Time frame: 16 weeks
  3. Number of daily basal rates at Week 16Time frame: Week 16

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The Regents of the University of California on behalf of its San Diego campus

    La Jolla, California

  • AMCR Institute, Inc.

    San Diego, California

  • Atlanta Diabetes Associates, Inc.

    Atlanta, Georgia

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.